Kenya is currently debating the Tobacco Control Amendment Bill, which has sparked controversy over its approach to nicotine products. The bill categorizes all nicotine products, including vapes and oral nicotine pouches, as "tobacco products," despite some containing no tobacco. Critics argue this approach is scientifically problematic, as it fails to distinguish between products that expose users to varying levels of toxicants and health risks.
The debate centers on the fact that cigarettes, vapes, and nicotine pouches contain nicotine but differ significantly in their health risks. Cigarettes, which involve burning tobacco, generate thousands of chemicals, including toxic and carcinogenic substances. In contrast, smoke-free nicotine products, such as vapes and pouches, avoid the combustion process and therefore expose users to fewer toxicants. This distinction is crucial in understanding the relative risks of these products.
Research has shown that smoke-free nicotine products can be effective tools for quitting smoking. A Cochrane living systematic review, updated in August 2026, found high-certainty evidence that nicotine vapes increase quit rates compared to conventional nicotine replacement therapy. Additionally, the US Food and Drug Administration authorized 20 nicotine pouch products to carry a modified-risk claim in June, allowing consumers to be informed that switching from cigarettes to these products lowers the risk of serious smoking-related diseases.
The issue of flavors in nicotine products has also sparked debate. While some argue that flavors appeal to children and should be restricted, others point out that non-tobacco flavors are commonly used by adults who vape and can help them quit smoking. Research by Yale University found that adults using flavored products are twice as likely to quit cigarettes than those using tobacco flavors.
The Harm Reduction Society of Kenya has emphasized the importance of a nuanced approach to regulating nicotine products. The organization's tobacco program is based on the principle that, where abstinence is achievable, it remains the lowest-risk option, but adults who continue to smoke should move to alternatives that expose them to fewer toxicants.
Public health experts argue that regulation can acknowledge that cigarettes, vapes, and nicotine pouches are not risk-free while also recognizing that they are not equally harmful. Accurate communication of these distinctions and policy debates that reflect the strength, limitations, and direction of the evidence are crucial in serving public health.
As Kenya considers the Tobacco Control Amendment Bill, it is essential that the science informs the policy debate. The bill's approach to nicotine products will have significant implications for public health, and experts hope that Kenya will get a tobacco bill that reflects the truth about the relative risks of these products.
Key points
- The bill's categorization of all nicotine products as "tobacco products" is scientifically problematic.
- Smoke-free nicotine products can be effective tools for quitting smoking.
- Regulation should acknowledge the differences in risk between cigarettes, vapes, and nicotine pouches.
